Page 32 - MemoriaCIBER2019-ENG
P. 32
32
CIBER Annual report 2019
As regards joint activities with groups from other thematic areas, we highlight the following projects:
• NANOCRISPRALBINO: Preclinical development of CRISPR-based non-viral therapeutic approaches in existing cellular and animal models of albinism, in collaboration with CIBERER and the participation of the group led by J.L. Pedraz.
• ALYCIA: Artificial Lymph Nodes for Cancer ImmunoTherapy, in collaboration with CIBERONC y and the participation of Judith Guasch (from the group led by J. Veciana).
CIBER-BBN nanomedicine researcher Luis M. Liz Marzán has once again been included in the list of Highly Cited Re- searchers by Clarivate Analytics, one of the most reputable classifications in the international academic and scientific community. We have participated in the following events related to the area of Nanomedicine: Nanomed Europe Conference, NME19 (Portugal), BioNanoNet Annual Meeting and Austrian Microfluidics Initiative (Salzburg, Austria) and 12th Annual Conference of Biomedical Research Technology Platforms (Madrid).
